Skip to main content

Table 1 Clinical and laboratory features of studied individuals according to diabetes duration and BMI status (univariate analysis)

From: Double-diabetes in a real-world sample of 2711 individuals: associated with insulin treatment or part of the heterogeneity of type 1 diabetes?

 

Diabetes duration <5 years

p

Diabetes duration ≥5 years

p

Normal

Overweight

Obesity

Normal

Overweight

Obesity

n

601

176

84

 

1275

462

113

 

Female gender (%)

54.4

56.3

50

NS

55.5

59.3

67.3

0.01*

Age (years)

13.5 (6.6)

13.1 (8.0)

9.8 (6.6)

<0.001

24.2 (11.5)

26.3 (12)

25.6 (13.9)

0.003

Diabetes duration (years)

2.32 (1.27)

2.20 (1.27)

2.20 (1.30)

NS

12.9 (7.4)

14.1 (8)

13.9 (9.3)

NS

Total insulin dose (U)

39.1 (21.8)

38.3 (21.0)

36.6 (23.7)

NS

51.7 (21.3)

59.1 (21.2)

60.1 (25.1)

<0.001

Insulin dose per body weight (U/kg)

0.90 (0.42)

0.82 (0.32)

0.83 (0.32)

NS

0.95 (0.38)

0.88 (0.34)

0.81 (0.34)

<0.001

Bolus/total insulin dose ratio (%)

22.6 (14.8)

21 (14.6)

20.8 (13)

NS

21.8 (14.7)

23.4 (15.1)

24.3 (15.1)

0.049

Number of insulin doses

4.71 (1.19)

4.66 (1.27)

4.90 (1.23)

NS

4.85 (1.20)

5.0 (1.20)

5.36 (1.17)

<0.001

BMI (kg/m2)

18.7 (2.66)

21.4 (3.55)

23.4 (5.21)

<0.001

21 (2.36)

25.5 (2.49)

29.5 (4.58)

<0.001

Body surface area (m2)

1.33 (0.35)

1.36 (0.40)

1.23 (0.45)

0.03

1.57 (0.24)

1.72 (0.23)

1.77 (0.30)

<0.001

Systolic blood pressure (mmHg)

101.6 (13.8)

102.7 (14.5)

103.1 (16.5)

NS

113.1 (16.3)

117.7 (17.4)

117.6 (16.7)

<0.001

Diastolic blood pressure (mmHg)

65.7 (10.4)

66.8 (11.7)

66.6 (9.7)

NS

72.3 (11)

74.4 (11.1)

74.2 (11.7)

0.001

Fasting plasma glucose (mmol/L)a

9.6 (5.8)

9.6 (5.4)

9.8 (4.9)

NS

10.1 (5.8)

10.2 (5.7)

9.9 (6.1)

NS

HbA1c (%)

9.2 (2.5)

8.9 (2.2)

8.8 (2.4)

NS

9.3 (2.3)

9.3 (2.3)

9.3 (2.3)

NS

HbA1c (mmol/mol)

78 (27)

74 (25)

73 (26)

NS

78 (25)

78 (25)

78 (25)

NS

Total cholesterol (mmol/L)b

4.20 (1.02)

4.18 (0.81)

4.27 (0.87)

NS

4.42 (1.05)

4.56 (1.14)

4.59 (1.23)

0.04

HDL-cholesterol (mmol/L)b

1.37 (0.37)

1.26 (0.30)

1.24 (0.27)

0.002

1.39 (0.39)

1.39 (0.41)

1.32 (0.34)

NS

LDL-cholesterol (mmol/L)b

2.43 (0.80)

2.49 (0.66)

2.65 (0.76)

NS

2.57 (0.85)

2.69 (0.87)

2.65 (0.86)

NS

Non-HDL-cholesterol (mmol/L)b

2.84 (0.97)

2.90 (0.71)

3.08 (0.83)

NS

3.02 (0.99)

3.17 (1.10)

3.26 (1.31)

NS

Triglycerides (mmol/L)c, d

0.73 [0.52–1.05]

0.80 [0.58–1.04]

0.76 [0.57–1.24]

NS

0.85 [0.61–1.14]

0.86 [0.64–1.29]

0.97 [0.68–1.46]

0.003

Familial history of type 2 diabetes (%)

8.4

14.4

10.7

NS

14.3

22.7

24.1

<0.001*

Overt nephropathy (%)

0

0

0

NS

4.8

1.9

2.9

0.04

Coronary events (%)

0

0

0

NS

0.7

0.9

0.9

NS

Number of cardiovascular risk factors

0.90 (0.87)

0.95 (0.93)

1.01 (0.95)

NS

0.93 (0.87)

1.28 (0.84)

1.30 (0.78)

<0.001

  1. Values are expressed in mean (SD), except where noted
  2. NS not significant
  3. * p for linear-by-linear association (Mantel–Haenszel test)
  4. a multiply by 18.018 to convert to mg/dL
  5. b multiply by 38.61 to convert to mg/dL
  6. c multiply by 88.5 to convert to mg/dL
  7. d median [interquartile range]